According to recent reports, residents of the states of the District of Colombia, Hawaii, Massachusetts, Missouri, Montana, Rhode Island, and Vermont, may have been victims of drug price fixing by generic drug companies.
Allegedly, the generic drug companies have been keeping the drug prices for certain drugs “artificially high” to satisfy their own interests.
According to reports, the alleged drug price fixing is a violation of both state and federal anti-trust laws.
The following drugs are those that may have been impacted by the drug price fixing conspiracy if purchased as far back as Oct. 1, 2012. The following drugs are: albuterol, amitriptyline, baclofen, benazepril & hydrochlorothiazide, clobetasol, digoxin, doxycycline hyclate, divalproex, desonide, econazole, fluocinonide, glyburide, levothyroxine, lidocaine & prilocaine, pravastatin, propranolol and ursodiol.
Drug Price Fixing Conspiracy Overview
According to reports, generic drug manufacturers who make drugs that have made the aforementioned list may have conspired to fix the prices of these drugs for many years.
The drugs that are also affected by the alleged drug price fixing conspiracy and price increases include medications to treat patients suffering from seizures, asthma and lung conditions, heart conditions, and infections, among other diagnoses.
The reports maintain that the executives at the generic drug companies colluded with each other in the alleged drug price fixing conspiracy in place. Moreover, the drug price fixing was “solidified through common trade association activities.”
The State Attorneys General and Justice Department had purportedly initiated an investigation into these generic drug companies, and soon after, they were also hit with lawsuits by several states and the federal government.
Allegations in these lawsuits have purported that these companies were engaged in a drug price fixing conspiracy. The Department of Justice had begun its investigation in 2014 and has purportedly continued through 2017.
The Government Accountability Office (GOA) also announced a report in 2012, maintaining that prices for the general prescription drugs when compared to their name-brand counterparts were 75 percent below the average price.
Moreover, Senator Bernie Sanders of Vermont and Representative Elijah Cummings of Maryland have maintained in a chart created by them that 10 of these generic drug prices shot up in price between 388 percent and 8,281 percent between October 2013 and April 2014.
The chart that was created originated from a report by the HSCA, or Healthcare Supply Chain Association.
Lives are being allegedly put at risk due to these increases and unaffordable drug costs. In a more recent lawsuit being brought to court, Arkansas, Missouri, New Mexico, West Virginia, and Washington, D.C., along with 40 other states, have filed lawsuits against several major drug companies.
The defendants facing the allegations are Heritage, Mylan, and Teva, which are being accused for drug price fixing general antibiotic and diabetes medications.
Join a Free Generic Prescription Drugs Price-Fixing Class Action Lawsuit Investigation
If you live in the District of Columbia, Hawaii, Massachusetts, Missouri, Montana, Rhode Island or Vermont and purchased prescription generic drugs, you may qualify to participate in this price-fixing class action lawsuit investigation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
